Inactivated COVID-19 vaccine
The inactivated COVID-19 vaccine produced by the Wuhan Institute of Biological Products Co., Ltd of China National Biotec Group Company Limited (CNBG) gained a clinical trial permit from the National Medical Products Administration on April 12, 2020, becoming the world's first of its kind.
So far, more than 50,000 volunteers of 125 nationalities have been vaccinated in phase III clinical trials.
The company will continue to push forward development of the vaccines following all requirements for guaranteeing of vaccine safety.
A photo of researchers of the inactivated COVID-19 vaccine [Photo/sasac.gov.cn]
